Voloridge Investment Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-26,855
Closed -$301K 1084
2019
Q2
$301K Buy
+26,855
New +$301K 0.01% 649